Novorapid and Transient ischaemic attack - a phase IV clinical study of FDA data
Summary:
Transient ischaemic attack is reported as a side effect among people who take Novorapid (insulin aspart recombinant), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Lantus, and have Type 2 diabetes.
The phase IV clinical study analyzes which people have Transient ischaemic attack when taking Novorapid. It is created by eHealthMe based on reports of 24,590 people who have side effects when taking Novorapid from the FDA, and is updated regularly.
What is Novorapid?
Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 24,730 Novorapid users. Check the latest studies of Novorapid.
What is Transient ischaemic attack?
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)) is found to be associated with 1,584 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Transient ischaemic attack.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
24,590 people reported to have side effects when taking Novorapid.
Among them, 46 people (0.19%) have Transient ischaemic attack.

Among these 46 people:
How long have people been on Novorapid when they have Transient ischaemic attack? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Transient ischaemic attack when taking Novorapid? *
- female: 52.27 %
- male: 47.73 %
What is the age of people who have Transient ischaemic attack when taking Novorapid? *
- 0-1: 0.0 %
- 2-9: 4.88 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 4.88 %
- 50-59: 12.2 %
- 60+: 78.05 %
What are other drugs people take besides Novorapid? *
- Lantus: 18 people, 39.13%
- Lasix: 7 people, 15.22%
- Ramipril: 5 people, 10.87%
- Xarelto: 5 people, 10.87%
- Actonel: 5 people, 10.87%
- Amlodipine: 5 people, 10.87%
- Plavix: 5 people, 10.87%
- Cimzia: 5 people, 10.87%
- Omeprazole: 4 people, 8.70%
- Flecainide Acetate: 4 people, 8.70%
What are other side effects people have besides Transient ischaemic attack? *
- Itching: 5 people, 10.87%
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 5 people, 10.87%
- Ischaemic Cerebral Infarction (ischemic stroke resulting from a disturbance in the blood vessels supplying blood to the brain): 2 people, 4.35%
- Depression: 2 people, 4.35%
- Hypoglycemia (low blood sugar): 2 people, 4.35%
- Hypoaesthesia (reduced sense of touch or sensation): 2 people, 4.35%
- Dizziness: 2 people, 4.35%
- Hyperglycemia (high blood sugar): 2 people, 4.35%
- Chest Pain: 2 people, 4.35%
- Malaise (a feeling of general discomfort or uneasiness): 2 people, 4.35%
What are the existing conditions these people have? *
- Type 2 Diabetes: 10 people, 21.74%
- High Blood Pressure: 7 people, 15.22%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 10.87%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 10.87%
- Dyslipidaemia (abnormal amount of lipids): 4 people, 8.70%
- Osteoporosis (bones weak and more likely to break): 3 people, 6.52%
- Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 6.52%
- Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 4.35%
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 4.35%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 4.35%
* Approximation only. Some reports may have incomplete information.
Do you take Novorapid and have Transient ischaemic attack?
- Check whether Transient ischaemic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Novorapid:
- Novorapid (24,730 reports)
Transient ischaemic attack treatments and more:
- Transient ischaemic attack (50,745 reports)
How severe was Transient ischaemic attack and when was it recovered:
Expand to all the drugs that have ingredients of insulin aspart recombinant:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Novorapid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Transient ischaemic attack:
- Transient ischaemic attack (1,584 drugs)
Browse all the conditions that are associated with Transient ischaemic attack:
- Transient ischaemic attack (1,643 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novorapid) and Novorapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Decadron cause Sinus Pain? - 5 seconds ago
- Zolpidem Tartrate vs. Tizanidine Hydrochloride, side effect and effectiveness comparison - 6 seconds ago
- Drug interactions of Meloxicam and Progesterone - 19 seconds ago
- Could Robitussin cause Hyponatraemia Aggravated? - 21 seconds ago
- Drug interactions of Spiriva and Norvir - 22 seconds ago
- Could Darunavir cause Cranial Nerve Palsies Multiple? - 31 seconds ago
- Drug interactions of Ditropan and Dantrium - 33 seconds ago
- Could Bicnu cause Fatigue? - 42 seconds ago
- Drug interactions of Zide and Celexa - 44 seconds ago
- Could Dalfampridine cause Maternal Exposure During Pregnancy? - 46 seconds ago